HomeINVO • NASDAQ
add
Invo Bioscience Inc
Previous close
$0.76
Day range
$0.75 - $0.80
Year range
$0.50 - $7.20
Market cap
2.93M USD
Avg Volume
97.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 1.58M | 352.92% |
Operating expense | 1.67M | -30.99% |
Net income | -1.60M | 37.41% |
Net profit margin | -101.28 | 86.18% |
Earnings per share | — | — |
EBITDA | -719.41K | 68.55% |
Effective tax rate | -0.12% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 475.12K | -78.29% |
Total assets | 18.32M | 197.79% |
Total liabilities | 18.31M | 201.97% |
Total equity | 10.16K | — |
Shares outstanding | 3.81M | — |
Price to book | -0.31 | — |
Return on assets | -12.07% | — |
Return on capital | -29.64% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -1.60M | 37.41% |
Cash from operations | -260.56K | 77.31% |
Cash from investing | -24.11K | -185.40% |
Cash from financing | 527.37K | -83.80% |
Net change in cash | 242.70K | -88.43% |
Free cash flow | 223.19K | 209.79% |
About
Founded
2007
Headquarters
Website
Employees
28